Sweden
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.18 B
|
Dec. 31, 2023 | USD 29.22 | -3.00% |
|
Sweden |
|
2 |
USD 1.93 B
|
Dec. 31, 2023 | USD 18.49 | 0.08% |
|
Sweden |
|
3 |
USD 1.71 B
|
Dec. 31, 2023 | USD 4.60 | 0.04% |
|
Sweden |
|
4 |
USD 1.31 B
|
Dec. 31, 2023 | USD 8.44 | 1.06% |
|
Sweden |
|
5 |
USD 1.02 B
|
Dec. 31, 2024 | USD 3.53 | -1.01% |
|
Sweden |
|
6 |
USD 955.91 M
|
Dec. 31, 2023 | USD 13.28 | -2.29% |
|
Sweden |
|
7 |
USD 952.36 M
|
Dec. 31, 2023 | USD 3.19 | -1.80% |
|
Sweden |
|
8 |
USD 366.15 M
|
Dec. 31, 2023 | USD 3.55 | -2.70% |
|
Sweden |
|
9 |
USD 346.63 M
|
Dec. 31, 2023 | USD 19.80 | -1.20% |
|
Sweden |
|
10 |
USD 169.45 M
|
Dec. 31, 2023 | USD 52.33 | -2.11% |
|
Sweden |
|
11 |
USD 135.52 M
|
Dec. 31, 2023 | USD 0.21 | -4.72% |
|
Sweden |
|
12 |
USD 81.39 M
|
Dec. 31, 2023 | USD 2.53 | -0.42% |
|
Sweden |
|
13 |
USD 74.02 M
|
Dec. 31, 2024 | USD 41.47 | -0.80% |
|
Sweden |
|
14 |
USD 66.85 M
|
Dec. 31, 2023 | USD 19.20 | -5.48% |
|
Sweden |
|
15 |
USD 63.05 M
|
Dec. 31, 2023 | USD 1.64 | -3.31% |
|
Sweden |
|
16 |
USD 60.80 M
|
Dec. 31, 2023 | USD 18.98 | -4.07% |
|
Sweden |
|
17 |
USD 56.39 M
|
Dec. 31, 2023 | USD 0.79 | -7.19% |
|
Sweden |
|
18 |
USD 29.11 M
|
Dec. 31, 2023 | USD 20.58 | -5.59% |
|
Sweden |
|
19 |
USD 23.31 M
|
Dec. 31, 2023 | USD 3.64 | -2.31% |
|
Sweden |
|
20 |
USD 16.82 M
|
Dec. 31, 2023 | USD 2.77 | -4.78% |
|
Sweden |
|
21 |
USD 15.62 M
|
Dec. 31, 2023 | USD 2.25 | -17.68% |
|
Sweden |
|
22 |
USD 15.19 M
|
Dec. 31, 2023 | USD 1.59 | -2.74% |
|
Sweden |
|
23 |
USD 13.24 M
|
Dec. 31, 2023 | USD 3.01 | -2.55% |
|
Sweden |
|
24 |
USD 8.30 M
|
Dec. 31, 2023 | USD 0.27 | -2.38% |
|
Sweden |
|
25 |
USD 8.30 M
|
Dec. 31, 2023 | USD 0.16 | -2.74% |
|
Sweden |
|
26 |
USD 7.05 M
|
Dec. 31, 2023 | USD 2.43 | -5.44% |
|
Sweden |
|
27 |
USD 5.69 M
|
Dec. 31, 2023 | USD 0.54 | -2.24% |
|
Sweden |
|
28 |
USD 5.47 M
|
April 30, 2024 | USD 0.13 | -1.11% |
|
Sweden |
|
29 |
USD 5.02 M
|
Dec. 31, 2023 | USD 0.13 | 0.88% |
|
Sweden |
|
30 |
USD 4.98 M
|
Dec. 31, 2023 | USD 0.14 | 2.05% |
|
Sweden |
|
31 |
USD 3.53 M
|
Dec. 31, 2023 | USD 0.50 | -2.16% |
|
Sweden |
|
32 |
USD 3.48 M
|
Dec. 31, 2023 | USD 0.16 | 9.53% |
|
Sweden |
|
33 |
USD 2.86 M
|
Dec. 31, 2023 | USD 0.22 | -4.95% |
|
Sweden |
|
34 |
USD 2.81 M
|
Dec. 31, 2023 | USD 0.71 | 8.98% |
|
Sweden |
|
35 |
USD 2.47 M
|
Dec. 31, 2023 | USD 0.81 | -4.47% |
|
Sweden |
|
36 |
USD 1.11 M
|
Dec. 31, 2023 | USD 0.31 | 1.24% |
|
Sweden |
|
37 |
USD 1.04 M
|
Dec. 31, 2023 | USD 0.84 | -2.95% |
|
Sweden |
|
38 |
USD 1.03 M
|
Aug. 31, 2024 | USD 0.26 | 0.92% |
|
Sweden |
|
39 |
USD 791.08 K
|
Dec. 31, 2023 | USD 0.09 | 11.18% |
|
Sweden |
|
40 |
USD 698.63 K
|
Dec. 31, 2023 | USD 0.39 | -4.99% |
|
Sweden |
|
41 |
USD 659.75 K
|
April 30, 2024 | USD 0.18 | -8.41% |
|
Sweden |
|
42 |
USD 560.42 K
|
Dec. 31, 2023 | USD 1.30 | -5.64% |
|
Sweden |
|
43 |
USD 547.20 K
|
Dec. 31, 2023 | USD 0.21 | 1.47% |
|
Sweden |
|
44 |
USD 278.53 K
|
Dec. 31, 2023 | USD 0.09 | -2.04% |
|
Sweden |
|
45 |
USD 144.40 K
|
Dec. 31, 2023 | USD 0.38 | -3.14% |
|
Sweden |
|
46 |
USD 142.42 K
|
Dec. 31, 2023 | USD 0.19 | -8.49% |
|
Sweden |
|
47 |
USD 102.15 K
|
Dec. 31, 2023 | USD 0.09 | -2.98% |
|
Sweden |
|
48 |
USD 31.39 K
|
Dec. 31, 2023 | USD 0.18 | -3.03% |
|
Sweden |
|
49 |
USD 26.65 K
|
Dec. 31, 2023 | USD 0.25 | -3.82% |
|
Sweden |
|
50 |
USD 12.60 K
|
Aug. 31, 2024 | USD 1.49 | -4.08% |
|
Sweden |
The Healthcare company in Sweden with the highest Revenue is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 2.18 B.
The Healthcare company in Sweden with the lowest Revenue is Vicore Pharma Holding AB (publ) (Stockholm Stock Exchange: VICO.ST) at USD 0.00.
The top 10 Healthcare companies in Sweden by Revenue are Swedish Orphan Biovitrum AB (publ), Medicover AB (publ), Attendo AB (publ), Ambea AB (publ), Arjo AB (publ), AddLife AB (publ), Humana AB (publ), Vimian Group AB (publ), Vitrolife AB (publ) and Camurus AB (publ).
The bottom 10 Healthcare companies in Sweden by Revenue are Vicore Pharma Holding AB (publ), Xspray Pharma AB (publ), AlzeCure Pharma AB (publ), Modus Therapeutics Holding AB (publ), Cantargia AB (publ), SynAct Pharma AB, Moberg Pharma AB (publ), Ascelia Pharma AB (publ), Guard Therapeutics International AB (publ) and OncoZenge AB (publ).